Targeted dosing to treat pediatric inflammatory bowel disease is challenging because dosing guidelines are based on data gathered from adult subjects of clinical trials. Patients’ families and health care organizations also incur high costs and must try to balance potential benefits against risks of ongoing monitoring.
AMA J Ethics. 2018;20(9):E841-848. doi:
10.1001/amajethics.2018.841.
Keisa Bennett, MD, MPH, Julie Phillips, MD, MPH, and Bridget Teevan, MS
Reasons for the shortage of primary care physicians in regions designated as Health Professional Shortage Areas and steps that medical schools and state and federal policymakers can take to alleviate the shortage.